Nucleic acid for all staff in Shanghai tomorrow! More than 230 doses of the new crown vaccine per 100 people in China! Second-generation recombinant protein new crown vaccine approved for clinical use – yqqlm

Key Data Concepts:   

? These are the company names, stock quotes, topics, and entities related to this data.

000739 000925 002014 002044 002326 002643 300151 300322 300639 300683 300713 300760 300832 Apeloa Pharmaceutical Brightgene Bio-Medical Technology Guangdong Hybribio Biotech Huangshan Novel Huizhou Speed Wireless Technology Meinian Onehealth Healthcare Holdings Shenzhen Changhong Technology Shenzhen Kingdom Sci-Tech Shenzhen Lifotronic Technology Shenzhen Mindray Bio-Medical Electronics Shenzhen New Industries Biomedical Engineering Shenzhenrease Technology Sichuan Changhong Electric Unittec Valiant Wuhan Hiteck Biological Pharma Zhejiang Yongtai Technology Science, Technology Research, Development Health, Beauty Product Pharmaceutical Construction, Property Design, Engineering Manufacturing, Engineering Market, Exchange Securities Stocks Diseases, Conditions Epidemic Medicine Vaccines People Government Biotechnology Technology, Engineering Population, Census Economy, Business, Finance Health

Full Data

?
UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on the Chinese Stock Markets

Join Now!

Need this critical market data?

Access thousands of market events, data points, and news articles!

Already have an account?
Login

Home » News » Nucleic acid for all staff in Shanghai tomorrow! More than 230 doses of the new crown vaccine per 100 people in China! Second-generation recombinant protein new crown vaccine approved for clinical use – yqqlm